INTRODUCTION
The mammalian cell nucleus is organized into distinct compartments (Mao et al, 2011) The severity of MN diseases correlates with a deficiency of SMN in the nucleus (Turner et al, 2009 ). The precise nuclear function of SMN is unknown. Nuclear import of the SMN complex depends on snRNPs (Narayanan et al, 2002 ) and targeting to CBs on its interaction with WRAP53 (for WD40 encoding RNA antisense to p53), a factor involved in CB recruitment of small CB-specific RNAs (Mahmoudi et al, 2010) . SMN has also been reported to form a different type of nuclear bodies designated gems for Gemini of CBs (Liu and Dreyfuss, 1996) . Gems contain the components of the SMN complex and lack coilin and snRNPs. Depletion of SMN disrupts CBs and gems, whereas coilin depletion disrupts CBs and forms gems (Lem et al, 2006; Whittom et al, 2008) . These data indicate that SMN is required for CB formation, and gems form when snRNP metabolism is disturbed. Thus, gems are thought to be storage sites. The tethering reaction of SMN has been reconstituted in cells,
showing de novo CB formation as a non-linear assembly process triggered by most components when SMN is present at sufficient levels (Kaiser et al, 2008) . However, understanding of mechanisms controlling the accumulation in CBs is so far not fully understood.
Many forms of stress, stimuli or signalling pathways impact on CB composition, size and number (Boulon et al, 2010) . These processes implicate significant changes in proteinprotein interactions influenced by post-translational modifications, such as protein methylation (Boisvert et al, 2002; Hebert et al, 2002; Clelland et al, 2009 ) and phosphorylation (Hebert, 2010) . SMN and coilin are phosphoproteins. The phosphorylation of SMN regulates the stability of the complex (Burnett et al, 2009 ) and snRNP assembly in the cytoplasm (Grimmler et al, 2005a) . Hyperphosphorylation of coilin coincides with lack of CBs during mitosis (Carmo-Fonseca et al, 1993) and SMN preferentially interacts with the hypophosphorylated coilin that forms CBs (Hebert et al, 2002) . The nuclear protein phosphatase PPM1G, which is not in CBs, contributes to the dephosphorylation of SMN and coilin and to their accumulation into CBs (Hearst et al, 2009; Petri et al, 2007) . Other studies on CBs have implicated phosphorylation. Inhibiting phosphatases and a phosphoserine mutation in coilin affect the CB localization of coilin and of snRNPs (Lyon et al, 1997; Sleeman et al, 1998) . The nuclear phosphatase PP4 associates with SMN complex and enhances the temporal CB localization of snRNPs (Carnegie et al, 2003) . Moreover, inhibition of PP1 has been shown to increase gem number in SMA fibroblasts (Novoyatleva et al, 2008) .
How PP1 could regulate SMN localization is unknown.
PP1 holoenzymes regulate a wide range of cellular functions, including transcription, pre-mRNA splicing, cell survival, synaptic plasticity and muscle contraction (Ceulemans and Bollen, 2004; Moorhead et al, 2007) . In mammalians, there are three PP1 catalytic subunits (α, β/δ and γ), each encoded by a different gene. The association with a regulatory (or targeting) subunit determines the subcellular localization and substrate specificity of the catalytic subunits (Cohen, 2002; Bollen and Beullens, 2002) . The list of about 180 regulatory subunits is still growing (Bollen et al, 2010) . Most targeting proteins harbour a primary consensus PP1-binding "R/KVXF" motif (Meiselbach et al, 2006) and the localization pattern of each catalytic subunit results from the addition of many different PP1 holoenzyme complexes. They all three localize in the cytoplasm and nucleus during interphase. PP1α and PP1γ are found in the nucleoplasm and PP1γ also concentrates in nucleoli, whereas PPP1β/δ is detected throughout the nucleus with no particular accumulation pattern (Andreassen et al, 1998) . The PP1 catalytic subunits are highly mobile and their subcellular localization could change with the expression levels of the targeting proteins (Trinkle-Mulcahy et al, 2001; . One of the major nuclear targeting subunits of PP1α and PP1γ is the phosphatase nuclear targeting subunit (PNUTS)/p99/PP1R10 that localizes in the nucleoplasm (Landsverk et al, 2005) and can be found occasionally in CBs (Moorhead et al, 2007) . These data illustrate how dynamic and transient could be the targeting of PP1 to different specific subcellular sites.
Using biochemical, proteomic, RNA interference and immunofluorescence approaches, we report here a novel mechanism of post-translational regulation of the SMN complex by PP1γ. For in vivo immunofluorescence experiments of control and SMA individuals we chose the skeletal muscle because of the very specific cytoplasmic organization. We examine the proteins coimmunopurified with SMN proteins and focus on a novel interaction with PP1γ. We identify Gemin8, a component of the SMN complex, as a novel PP1-binding protein targeting PP1γ to CBs. We show that modulating the expression levels of PP1γ impact on the subnuclear organization. Our results support the conclusion that PP1γ could regulate SMN complex formation and localization to CBs.
RESULTS

Proteomics study of the N-terminal region of SMN
We previously produced SMN deletion mutants in order to gain insight into its subnuclear localization in mammalian cells (Renvoisé et al, 2006) . A diagram of the domains used here for fluorescent fusion protein is shown in Figure 1A . The fragment containing the lysine-rich region (aa 71-83) and Tudor domain (aa 91-151) produced a fusion GFP-472Δ5 that localizes to the nucleoplasm and CBs. Introduction of mutations in the lysine-rich region of GFP-472Δ5 abolishes the localization in CBs. We expressed the N-terminal region of SMN as GFP fusion (GFP-N86, 86 first aa) and performed immunoprecipitation (IP) experiments with anti-GFP antibody to identify new interaction partners of SMN (Fig. 1B-C) . In co-IPed proteins, we observed a major band of about 40 kDa corresponding to the apparent mass of GFP-N86 (Fig. 1C) . The band was cut, digested and analysed by mass spectrometry (MS).
Peptides from GFP-N86 and from protein phosphatase PP1γ, as a candidate partner of expected mass, were detected ( Fig. S1 ). We sought to determine the relationship between PP1γ and SMN because SMN complex localization and function are regulated by protein phosphorylation.
Coimmunoprecipitation of PP1γ with SMN complex
To test the association of PP1γ with SMN, we expressed GFP-SMN472Δ5, GFP-N86
and GFP-N86M2 fusion proteins and performed co-IP experiments (Fig. 1D ). Immunoblot analyses revealed that PP1γ was co-IPed with GFP-SMN472Δ5 and GFP-N86. We found little if any interaction between PP1γ and GFP-N86M2, a fusion protein in which the lysine residues are mutated (Renvoisé et al, 2006) . This mutation disrupts a minor self-interacting motif of SMN that could regulate stability and CB localization of SMN complex (Morse et al, 2007) . Our attempt to detect the interaction between endogenous SMN and PP1γ proteins was less efficient (data not shown) than between GFP-SMN and PP1γ (Fig. 1E ), suggesting that either the anti-SMN antibody masks the interaction site or a third component mediates the interaction between them.
Direct interaction of PP1γ with SMN complex and its component Gemin8
A pull-down assay was used to demonstrate direct interaction between PP1γ and SMN complex (Fig. 2) . Anti-SMN antibody 4B3 allowed us to purify the SMN complex from HeLa cell lysates under stringent conditions in order to remove any interacting proteins of weak affinity for the complex ( Fig. 2A) . The antibody-immobilized complex (SMN complex) was incubated with a purified Escherichia coli recombinant His-tagged PP1γ (His-PP1γ). After extensive washes, the proteins bound to the complex were eluted and tested for the presence of His-PP1γ by immunoblotting (Fig. 2B ). The bound proteins were compared with that bound to unrelated mouse monoclonal antibody (Control). The recombinant PP1γ was bound to SMN complex. We then sought to identify the component of the complex that mediates binding to PP1γ. The most common PP1-binding RVXF-motif has the consensus sequence between Gemin8 and PP1γ was tested using purified bacterial recombinant proteins (Fig. 2C ).
The immobilized glutathione S-transferase (GST)-tagged Gemin8 retained His-PP1γ, whereas the GST alone did not (Fig. 2D ). Direct interaction between Gemin8 and PP1γ was further tested in fixed HeLa cells using the in situ proximity ligation assay (in situ PLA, Fig. 2E ).
This approach detects endogenous protein-protein interactions in fixed cells using antibodies specific for each protein (Fredriksson et al, 2002) . Using in situ PLA, the Gemin8-PP1γ interaction appeared as bright dots in the cytoplasm, nucleoplasm and CBs. Moreover, endogenous Gemin8 interacted with PP1γ and SMN in co-IP experiments (Fig. 2F) . Our results support the conclusion that Gemin8 is a PP1-binding protein.
Over-expression of Gemin8 colocalizes PP1γ with CB markers
Given that PP1-binding proteins confer subcellular localization and substrate specificity to PP1 holoenzymes, Gemin8 was expressed as a fluorescent fusion (FP-Gemin8, Fig. 3A ) and its colocalization with SMN and PP1γ was tested. FP-Gemin8 completely colocalized with SMN to the cytoplasm and nuclear bodies CBs, as reported (Fig 3B; Carissimi et al, 2006) . In FP-Gemin8 expressing cells, PP1γ was concentrated in numerous nuclear bodies with the fusion, whereas it was concentrated in nucleoli of untransfected cells or of cells expressing either FP-SMN, myc-Gemin4 or FP-alone ( Fig 3C) . Colocalization with FP-Gemin8 could be due to the presence of other PP1-binding proteins in CBs. The Cterminal region of Gemin8 including the coiled coil domain (FP-G8ΔC) was deleted to reduce nuclear body formation and we introduced mutations in the putative PP1-binding motif (FP-G8ΔC3A, Fig. 3A , C). Both FP-G8ΔC and FP-G8ΔC3A localized to the nucleoplasm and to fewer CBs. FP-G8ΔC recruited PP1γ into CBs, whereas FP-G8ΔC3A did not. These experiments revealed that the HVAW-motif of Gemin8 is required for the localization of PP1γ to CBs. All together, our results support the conclusion that Gemin8 contributes to CB localization of PP1γ in mammalian cells.
To determine whether the FP-Gemin8 nuclear bodies contained other CB constituents, colocalization with coilin (CB marker), Gemin3 and components of snRNPs was examined ( Fig. 4A-E) . All FP-Gemin8 nuclear bodies were CBs as indicated by complete colocalization with coilin. They were also enriched in Gemin3 and snRNP-specific markers, such as the TMG-capped snRNAs (molecular signature for the nuclear import of snRNAs), snRNP Sm core protein SmD3 (one of the seven Sm proteins common to all snRNPs except U6 snRNP) and U1-specific 70kDa protein. The localization of the abundant splicing factor SC35 that is a marker of speckles (Spector, 1993) and does not concentrate in CBs was investigated. Figure   4F showed that SC35 staining occurs in speckles and not in CBs of FP-Gemin8 expressing cells, supporting the conclusion that the accumulation of PP1γ in CBs is specific. Our results demonstrated that Gemin8 could form CBs, which contain SMN complex, snRNPs and PP1γ.
Depletion of PP1γ enhances the accumulation of SMN complex and snRNPs in CBs
To determine whether there might be a functional link between PP1γ and SMN targeting to CBs, RNA interference (RNAi) knockdown experiments were performed using three distinct PP1γ−specific small interfering RNA (siRNA) duplexes (Fig. 5 ). We first tested the protein levels of total lysates of HeLa cells transfected with either a negative control firefly luciferase (Gl2) or PP1γ siRNAs (si#5, si#6 and si#8) by immunoblotting. The PP1γ-specific siRNAs reduced PP1γ protein levels by about 65% (Fig. 5A ). SMN complex levels remained the same, indicating the specificity of the siRNAs used to reduce PP1γ levels. As control, the overall phosphorylation profile of total protein lysates was examined ( Depletion of PP1γ (as shown by the reduced PP1γ staining) led to a significant increase in the proportion of cells with more SMN nuclear bodies compared with controls ( Fig. 5B, C ). There was a three-to four-fold increase in the proportion of cells with more than five nuclear bodies.
All three PP1γ siRNAs confirmed the formation of CBs upon depletion of PP1γ (Fig. 5C ).
Colocalization experiments with coilin and CB components, including Gemin3, Gemin8 and snRNP-specific markers, resulted in similar observations ( Fig. 6A-F ). These data indicated that depletion of PP1γ increases CB numbers and has no adverse effect on their composition.
In the nucleus, SMN is localized with coilin in CBs, and in their twin nuclear bodies gems that lack coilin and snRNPs (Liu and Dreyfuss, 1996) . To examine whether SMN localizes in either nuclear bodies of PP1γ-depleted cells, triple immunolabelling experiments were performed with PP1γ, SMN and coilin antibodies ( Fig. 7 A-D) . In control Gl2 siRNAtreated cells SMN localized in both gems and CBs (Fig. 7A ), whereas depletion of PP1γ led to complete localization of SMN in CBs (Fig. 7B) . To demonstrate the specificity of the effects observed above, FP-PP1γ was expressed using a cDNA resistant to siRNA#5 (Fig. 7C ). FP-PP1γ expression restored SMN localization in gems and CBs, whereas FP alone did not ( (Grimmler et al, 2005a) . Examination of SMN isoforms from PP1γ-depleted cell extracts revealed striking differences. First, SMN phosphorylation increased upon depletion of PP1γ as indicated by the accumulation of more acidic isoforms (section 1), whereas expression of FP-PP1γ reduced them. Second, the spots at pH 6.8 (section 2) and pH 8.5 (section 3) that were reduced upon PP1γ depletion (arrows, Fig. 7G ) were also rescued by FP-PP1γ. Third, a basic isoform of section 4 (at pH 9.2, arrowhead) accumulated in PP1γ-depleted extracts, whereas FP-PP1γ caused it to disappear and a slightly less basic spot to form. Finally, overall populations of spots from section 2 to 4
were partially rescued by FP-PP1γ. Our results support the conclusion that PP1γ regulates changes in the post-translational modification pattern of SMN.
Depletion of PP1γ results in an increased association of SMN and Gemins
We tested the possibility that the increased CB number demonstrated above in PP1γ-depleted cells might correlate with accumulation of the SMN complex in the nucleus.
Cytosolic and nuclear fractions were prepared from HeLa cells transfected with either Gl2 or PP1γ siRNAs and the distribution of the SMN complex was monitored by immunoblotting ( Fig. 8A) . It was not possible to probe for Gemins 5, 6 and 7 due to the limited affinities of commercial antibodies. Gemin8 and unrip were predominantly cytosolic as reported (Carrissimi et al, 2005 (Carrissimi et al, , 2006 Grimmler et al, 2005b ). There was no major change in the nucleocytoplasmic distribution of SMN complex, indicating that PP1γ is not involved in this process.
Given the role of phosphorylation in protein-protein interactions, we tested whether PP1γ might regulate the association of the Gemins with SMN. To this effect, cytosolic and nuclear fractions were immunoprecipitated using anti-SMN antibodies, and co-IPed proteins were analysed by immunoblotting ( Fig. 8B-D) . In SMN complexes from the cytosol of PP1γ-depleted cells, Gemins 4, 8 and unrip were significantly increased relative to SMN, whereas Gemins 2 and 3 were not (Fig. 8C ). Similar changes were found when the nuclear SMN complexes were examined (Fig. 8D ). This indicated no major change in the association of SMN/Gemin2/Gemin3 sub-complex, while the association of the peripheral Gemins changed.
As described previously (Carissimi et al, 2006; Charroux et al, 2000; Otter et al, 2007) , SMN interacts directly with Gemin8, and Gemin3 with Gemin4. Our results support the conclusion that PP1γ regulates these interactions.
PP1γ and Gemin8 colocalize in the cytoplasm of skeletal muscles
As a first approach to understand in vivo the physiological relevance of the interaction between Gemin8 and PP1γ demonstrated here, we sought to determine their colocalization in mammalian tissue sections. The skeletal muscle was chosen for its specific subcellular organization and localization of SMN complex at the z-discs of mouse myofibrils (Walker et al, 2008) . Using the Prestige anti-Gemin8 antibodies validated by the Human Protein Atlas project in numerous tissues including the skeletal muscle (www.proteinatlas.org), the expected striated pattern of Z-discs was obtained on 14-day post-natal mouse and human foetal skeletal muscles ( Fig. 9A-B) . Our colocalization experiments revealed significant, although not complete, overlap of PP1γ with Gemin8. These results support the conclusion that Gemin8 and PP1γ could colocalize in vivo.
Our previous studies have shown a marked reduction of SMN levels in skeletal muscles from foetuses with severe SMA (Burlet et al, 1998 , Fig. 9D ). Morphological defects consistent with a Z-disc deficiency have been reported in a mouse model with severe SMA (Walker et al, 2008; Kariya et al, 2008) . To address the question of whether similar defects occur in the human disease, colocalization experiments were carried out on muscle sections from SMA foetuses (Fig.9C ). An altered organization of the striated pattern was observed as indicated by aberrant Gemin8 and PP1γ localization and a severe atrophy reflecting denervated fibers. To provide molecular insights into pathobiology, control and severe SMA fibroblast cell extracts were immunoprecipitated using anti-Gemin8 antibodies and co-IPed proteins were analysed by immunoblotting (Fig. 9E ). As reported previously (Lefebvre et al, 2002 ), a reduction of SMN levels of about 75% is detected in SMA fibroblast cell cultures compared with control fibroblasts. There was a significant 2.5-fold decrease in interaction between SMN and Gemin8 or PP1γ in SMA fibroblasts, whereas no significant difference of the Gemin8 interaction with PP1γ was detected (Fig. 9F) . This is consistent with the two-to three-fold reduction of in vitro snRNP assembly activity previously reported with SMA fibroblast cell extracts (Gabanella et al, 2007; Wan et al, 2005) . Our results support the conclusion that the production of SMN complex is less efficient in SMA conditions.
DISCUSSION
The SMN complex plays a central role in snRNPs biogenesis (Fischer et al, 1997) and in SMA, the second most frequent autosomal recessive disease of children (Lefebvre et al, 1995) . snRNP biogenesis is fundamental for splicing and transcriptome integrity (Kaida et al, 2010) . One key consequence of splicing activity in cells is the accumulation of SMN and snRNPs in nuclear bodies CBs (Liu and Dreyfuss, 1996; Carvahlo et al, 1999) , a localization disrupted in SMA motor neurones (Lefebvre et al, 1997) . Understanding the mechanisms underlying SMN interaction is important for cell survival in general and particularly for the development of SMA therapy. Using coimmunoprecipitation experiments we identify here a novel regulator of SMN complex. Protein phosphatase PP1γ interacts with the complex, regulates its formation and localization to CBs.
Gemin8 binds directly to PP1γ and brings it into the multiprotein SMN complex, which is essential for snRNP biogenesis. SMN complex subunits associate in a stepwise manner in the cytoplasm along snRNP biogenesis pathway (Carissimi et al, 2006; Massenet et al, 2002; Yong et al, 2010) . Direct Gemin8 binding to SMN is the heart of the association of subunits made of SMN/Gemin2 and Gemin6/7/8/unrip into an intermediate complex that is competent to associate the Sm proteins of snRNPs. Thereafter, Gemin5 bound to the presnRNA and Gemins 3 and 4 are considered to separately join the intermediate complex. We observed here that the reduction of PP1γ levels enhances SMN interaction with Gemin8 and the number of CBs. As suggested by a mathematical model predicting that CBs accelerates snRNP biogenesis (Klingauf et al, 2006) , our data indicate that PP1γ depletion enhances the cytoplasmic assembly of snRNPs and thus, their nuclear import and accumulation in CBs.
Our observations suggest that the formation of an intermediate complex made of SMN/Gemin2 and Gemin6/7/8/unrip is regulated by phosphorylation. We propose that PP1γ
regulates the phosphorylation state of SMN to prevent premature formation of the intermediate complex. Although the exact PP1γ target sites of SMN are unknown, 2D-gel analyses reveal that lowering PP1γ levels accumulates hyperphosphorylated SMN (Fig. 7) .
Moreover, a reduction in the extent of SMN phosphorylation was observed by expressing PP1γ in PP1γ-depleted cells that correlates with a lower CB number, reflecting downregulation of snRNP biogenesis. A link is provided between previous studies showing that SMN complex formation depends on SMN phosphorylation (Grimmler et al, 2005a; Burnett et al, 2009 ) and its interaction with Gemin8 (Carrisimi et al, 2006) .
Other studies have shown by dephosphorylating SMN in the nucleoplasm, PP1MG
regulates SMN complex stability in CBs (Petri et al, 2007) . Consistent with our findings, PP1MG activity is probably not altered in PP1γ-depleted cells. The Gemin8 interaction with PP1γ in CBs (Fig. 2E) suggests that the two phosphatases function in different subnuclear compartments. Although SMN is the best candidate for a PP1γ substrate, other proteins interacting with Gemin8 or located in the vicinity may also be candidates as well. There are sixteen potential phosphoserines in SMN. It will be interesting to determine whether PP1γ targets the same residues as PP1MG and if not, this may explain why depletion of PP1MG decreases SMN localization to CBs (Petri et al, 2007) , whereas PP1γ depletion increases it.
Regulation of SMN interactions could stabilize the complex (Burnett et al, 2009; Ogawa et al, 2009) . SMA mutations in the C-terminal region prevent self-oligomerization (Lorson et al, 1998 ) that disrupts Gemin8 binding to SMN and hinder SMN complex formation (Otter et al, 2007) . There is a second minor self-oligomerization domain lying in the Lys-rich domain of SMN (Morse et al, 2007) . Indeed, PP1γ interaction with SMN complex appears to require two elements, the self-oligomerization Lys-rich domain of SMN ( Fig. 1) and Gemin8 (Fig.2) . Dependence on the production of a functional SMN complex would provide a rationale for the failure of PP1γ to associate with a mutant lacking the selfoligomerization domains. Another possibility is that the phosphoserine S80p (MS information, PhosphositePlus) located within the Lys-rich domain might be sensitive to PP1γ.
This aspect awaits further investigation.
It is worth noting that SMA modelling in Drosophila melanogaster and
Caenorhabditis elegans has identified PP1 regulatory (inhibitory) subunit 13B (PP1R13B) as a modifier of SMN-deficiency phenotypes (Chang et al, 2008; Dimitriadi et al, 2010) . This is consistent with our model that ablation of the PP1 regulatory subunit exacerbates SMNrelated defects by up-regulating PP1. Only SMN and Gemins 2, 3 and 5 has been identified in Drosophila (Kroiss et al, 2009 (Garcia et al, 2004 ) and D-X-X-D-X-X-X-D (Neduva et al, 2005) . The former motif occurs in Gemin4 and the latter in SMN. We have shown here that neither Gemin4 nor SMN recruits PP1γ to CBs (Fig. 3) . Collectively, our results are most consistent with Gemin8 targeting PP1γ to CBs. The similarity of effects upon Gemin8 overexpression (Fig. 4) and PP1γ depletion (Fig. 6) indicate that Gemin8 is a novel regulatory subunit of PP1.
Loss of SMN leads to motor neuron degeneration and muscle atrophy in SMA. The importance of SMN in muscles is beginning to be appreciated given the various degrees in disease severity (Bosch-Marcé et al, 2011; Kariya et al, 2008; Mutsaers et al, 2011) . Although the mechanisms are still elusive, several observations can be considered. Lowering SMN in cultured cells alters fusion and morphology of differentiated myoblasts (Shafey et al, 2005) .
Ablation of the muscular SMN causes loss of regeneration by satellite cells (Nicole et al, 2003) . Moreover, localization of SMN complex with α-actinin at the level of Z-discs suggests a function outside snRNP biogenesis (Walker et al, 2008) . Our observations that PP1γ and Gemin8 colocalize at Z-discs indicate that PP1γ could regulate a function of SMN complex in vivo (Fig. 9) . Lack of subcellular organization and aberrant localization of Gemin8 and PP1γ as observed in SMA muscles would compare well with the Z-disc phenotype in SMA mouse models (Walker et al, 2008) . Another interesting observation is that the interaction of PP1γ
with SMN is reduced in SMA cells. These defects may impair the regulation of SMN complex in SMA.
Plausible strategy for the development of therapeutics in SMA is to increase SMN protein levels (Lorson et al, 2010) . The physiological relevance of our data is that a specific manipulation of PP1γ might impact on SMN complex independently of an increase in SMN levels ( Fig. 5, 8 ). However, pharmacological ablation of all three PP1 catalytic subunits causes formation of SMN nuclear body gems in SMA cells (Novoyatleva et al, 2008 ; our unpublished data). Since gems are storage sites formed when pre-mRNA splicing is inhibited, more specific molecules will be required. Modelling the interaction shown here between PP1γ and SMN complex may be a promising target in SMA therapy. Future in vivo experiments will need to address whether this has any beneficial effects in models.
Remarkable pleiotropy is seen for PP1 holoenzymes in distinct cellular pathways, including the EGF, TGF-β and FGF signalling pathways that have been linked to SMN (Bruns et al, 2009; Chang et al, 2008; Gangwani et al, 2001; Sen et al, 2011) . Our studies reveal a regulation of SMN complex and of nuclear body formation by PP1γ, identify Gemin8 as directly interacting with PP1γ, show mis-localization of PP1γ and Gemin8 in SMA muscles in vivo and altered interaction of PP1γ with SMN in SMA cells. A tight regulation of SMN complex assembly is revealed. It is therefore possible that imbalance of SMN sub-complexes produced by the reduction of SMN contributes to SMA severity.
MATERIALS AND METHODS
Cell culture and transfections
COS7 and HeLa cell cultures were maintained in DMEM supplemented with 10% FBS, penicillin (100 U/ml) and streptomycin (100 g/ml) in a humidified CO 2 incubator at 37°C.
HeLa cells were plated in 60 mm dishes or 8-chamber culture slides (Becton Dickson) for transfected using HiPerFect transfection reagent (Quiagen) with PP1γ-validated siRNAs (Hs_PPP1CC_5, _6 and _8) and negative controls Gl2 or scrambled duplexes (25 nM). For the rescue experiments, HeLa cells were first transfected with siRNA (Hs_PPP1CC_5) and 16-hr later the cells were transfected with pdEYFP-PP1γ plasmid (IOH14587-pdEYFPC1amp, imaGenes) using Transmessanger reagent (Qiagen). After 5-hr incubation, the medium was changed to fresh medium further incubated for 21 hours. Using FuGENE (Roche), HeLa cells were transfected with expression plasmids for pEGFP-SMN (Renvoisé et al, 2006) , myc-Gemin4 (a gift from S. Massenet, CNRS, Nancy) and pdEYFP-Gemin8
(IOH3877-pdEYFP-C1amp, imaGenes), and pdEYFP-Gemin8ΔC or pdEYFP-Gemin8ΔC3A.
Indirect immunofluorescence
Forty-two hours post-transfection with siRNAs or 21 h with DNA plasmids, HeLa cells were prepared for indirect immunofluorescence microscopy as described (Renvoisé et al, 2006) .
Briefly, transfected cells were fixed in 4% formaldehyde, permeabilized with 0.5% Triton X-100 and incubated with the following antibodies (that are polyclonal or otherwise designated as monoclonal using mAb): anti-SMN at 1:1000, mouse mAb 4B3 (Burlet et al, 1998) DNA staining 4, 6-diamidino-2-phenylindole (DAPI, Molecular probes). Cryosections (7-10 μm) of muscle tissues from mouse (provided by J Cartaud) and human foetuses frozen at -80°C in isopentane were mounted for immunostaining as described (Lefebvre et al, 1997; Burlet et al, 1998) .
In situ proximity ligation assay (PLA)
In situ PLA assay was performed as recommended by the manufacturer (DuolinkII kit, Olink Bioscience AB). Briefly, HeLa cells were fixed and permeabilized as above. Primary antibodies were diluted at 1.75 ng/μl rabbit anti-Gemin8 (Atlas antibodies, Sigma) and 2 ng/μl goat anti-PP1γ (C19, SC) in 1x antibody diluent and incubated for 30 min at room temperature. The negative control consisted in using only one primary antibody. The cells were washed twice for 5 min in TBS-T (0.05% tween). The PLA probes (Rabbit-MINUS and Goat-PLUS) were incubated for 90 min at 37°C. Subsequent steps were performed using the detection reagents Orange according to DuolinkII kit protocol. In situ PLA signals were visualized as dots with the RITC-filter on microscope. Incubation with DAPI served to counterstain for nuclei in order to select image position.
Image acquisition and manipulation
Immunofluorescence signals were observed by nonconfocal microscopy (Leica DMR, objective 63x/1,32). Black-and-white images were acquired with a cooled CCD camera (Micromax, Princetown Instruments, Inc.) using the MetaView Imaging System. Figures were processed and assembled with Photoshop (Adobe).
Protein extract preparation and immunoprecipitation
Cytosolic-nuclear fractionation was with NE-PER kit (Pierce Chemical Co). For immunoprecipitation, the cytosolic fractions were used directly and isolated nuclei or frozen cell pellets were resuspended in IP (or RIPA) buffer (50 mM Tris-HCl [pH 7.4], 150 mM NaCl, 1% NP40, EDTA-free protease inhibitors (Roche) cocktail), passed through a 27-gauge needle and clarified by centrifugation at 15,000 g for 15 min at 4°C. 25 μl of protein G dynabeads (Invitrogen) were covalently bound to 10 μg of the following antibodies according to manufacturer procedures: mouse monoclonal anti-GFP (Roche), mouse monoclonal anti-SMN 4B3 or mouse negative control antibodies (DAKO). The coated dynabeads were incubated with protein extracts for 1 h at 4°C. After five-to-seven washes in 1 ml of IP buffer (with 150 or 500 mM NaCl as indicated), the bound proteins were eluted by boiling in 2 X SDS sample buffer and resolved by SDS-PAGE. Crosslinked experiments with dithiobis[succinimidyl propionate] (Pierce) of cultured COS cells expressing either GFP-SMN or GFP-N86M2 were used to facilitate the biochemical analysis for Fig.1E only. The anti-Gemin8 immunoprecipitations were performed in the IP buffer containing 0.01% SDS using rabbit anti-Gemin8 antibodies (Santa Cruz) and negative control rabbit antibodies (DAKO).
Protein expression and purification
His-tagged PP1γ was expressed from IOH14587-pDEST17-D18 (imaGenes) in E. coli BL21 (DE3) pLysS (Stratagene) at 30°C for 5 h and purified on Ni-NTA agarose (Qiagen) as previously described for His-tagged proteins (Lefebvre et al, 2002) . Purified His-PP1γ was either used immediately or snap-frozen and kept at -80°C. GST vector (Pharmacia) and GSTGemin8 (IOH3877-pDEST15, imaGenes) were expressed in E. coli Rosetta2 (DE3) pLysS (Novagen, Merck) at room temperature for 5 h. Recombinant GST proteins were purified and retained on magnetic beads (magneGST protein purification system, Promega) for proteinbinding assays or eluted by boiling in 2 X SDS sample buffer and resolved by SDS-PAGE.
In vitro protein-binding assay
SMN complex was immunopurified from HeLa whole-cell extracts with monoclonal antibody 4B3 under stringent conditions (500 mM NaCl and 0.1% NP40) on magnetic dynabeads as described above. The immobilized proteins (SMN complex or GST proteins, 12.5 μl of magnetic beads slurry) were pre-incubated 5 min with 1 mg/ml BSA, washed and incubated for 30 to 60 min at 4°C with 2,5 μg of purified recombinant His-tagged PP1γ in 25 μl of binding buffer containing 20 mM Tris-HCl [pH 7.5], 150 mM NaCl, 0.5 mM MnCl 2 , 1 mM DTT and 0.05% NP40. The bound proteins were washed five to seven times with 500 μl of ice-cold binding buffer and eluted by boiling in 2X SDS sample buffer.
Protein separation and immunoblot analysis
Protein samples were separated by 11% SDS-PAGE (Prosieve acrylamide) or a 4-12% gradient (Invitrogen) and electrotransferred to PVDF membranes (Millipore). Immunoblots were performed as described previously (Renvoisé et al, 2006) , revealed by chemiluminescence (ECL; GE Healthcare) and exposed to Fuji high-speed x-ray films or captured with fujiflim LSA-3000 camera system. The following antibodies were used: anti-SMN (mouse mAb 4B3 at 1:5000), anti-Gemin2 and 3 (mouse mAb at 1:500, Abcam), Gemin4 (goat at 1:4000, SC), Gemin8 (mouse mAb at 1:1000, Abcam), PP1α (rabbit at 1:10000, SC), PP1γ (goat at 1:10000, Santa Cruz), α-tubulin (mouse mAb at 1:10000, Sigma), HDAC (rabbit at 1:500, SC), phosphoserine (rabbit at 1:200, Invitrogen), GFP (mouse at 1:1000, Roche or rabbit at 1:5000, Abcam) and horse radish peroxydase-conjugated IgG (at 1:10 000, GE Healthcare or SC). For 2D-gel electrophoresis, the nuclear pellets prepared using the NE-PER kit were directly solubilized in 8 M urea, 1 M thiourea, 2.5% CHAPS, 23 mM DTT and 0.5% IPG using a 27-gauge needle, and a first-dimension was performed in strips with immobilized pH gradient (IPG) using pH 3-10 linear IPG drystrips (GE Healthcare) at the Institut Jacques Monod proteomics facility. Statistical analyses of ECL signals were performed with ImageJ using grayscale images generated with Epson Perfection 4990 PHOTO transparency scanner (1000 dpi images, as shown in the figures assembled with Photoshop) or with luminescent analyser LAS-3000 camera system (Fujifilm).
Candidate proteins by mass spectroscopy
Coimmunopurified proteins were separated by SDS-PAGE and visualized by massspectrometry-compatible silver staining (Silver Quest, Invitrogen). The bands of interest were excised, extensively digested with trypsin and extracted peptides were analysed using alphacyano-4-hydroxycinnamic acid (CHCA) matrix on a 4800 TOF-TOF mass spectrometer 
